Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings
These three top biotech names are very good bets for investors looking to add high-quality companies with less volatility and binary clinical data risk.
All Work
Lee Jackson
4 Merrill Lynch Buy-Rated Technology Stocks That Pay Big Dividends
While these technology leaders are still more suitable for aggressive growth accounts, the sector leadership combined with the strong dividends make them good bets for patient long-term technology investors.
4 Top Jefferies Value Stock Picks to Buy Now
In a new report, Jefferies has a plethora of new value calls, and these four top stocks could be solid winners.
Oppenheimer Starts Coverage on Clean Tech Stocks With Huge Upside
Oppenheimer has initiated coverage on two companies and upgrades another that could all thrive in the clean-tech arena.
JPMorgan Makes Winning Calls, Says Continue to Buy Chip Stocks
JPMorgan thinks that 2016 looks better for chips and chip equipment, and given the rough 2015, it is a good-looking sector valuewise.
UBS Makes Big Changes to Quality Growth at a Reasonable Price Portfolio
The UBS focus on buying good stocks at a good value makes even more sense now than ever.
Jefferies Has Turned Very Bullish on Oil: 6 Top Reasons Why
Six words that nobody ever likes to hear uttered -- "this time it may be different" -- may just make sense now.
5 Dividend-Paying Blue Chip Stocks Trading Under 15 Times Forward Earnings
The bottom line is volatility at higher levels may be here to stay for some time. Owning low-multiple, dividend-paying blue chip leaders makes good sense for long-term growth portfolios.
Top-Performing UBS Dividend Ruler Stocks Portfolio Makes Q4 Changes
While the UBS Dividend Rulers portfolio has underperformed so far this year, it is very possibly a function of the market overestimating the timing and extent of interest rates increases.
Jefferies Out With 3 New Top Growth Stocks to Buy Now
In a new report, Jefferies is out with three very good new growth stock ideas for investors. Two of the picks are aggressive biotech and medical device plays, and one a leading retailer.
4 Cheap Chip Stocks to Buy Now Before Q3 Earnings
Stifel points to four specific semiconductor stocks it feels currently trade at relatively attractive valuations. All are rated Buy at the firm as well.
After EMC, Which Top Storage Stock Is the Next Big M&A Target?
Oppenheimer makes it clear it thinks change is on the way and a EMC/Dell combination could spark a consolidation trend across the sector.
Jefferies Franchise Pick Stocks to Buy That Also Pay Big Dividends
These Jefferies Franchise picks with solid dividends are perfect for long-term accounts that like to employ a buy-and-hold strategy.
Deutsche Bank Slashes Price Targets on Chip Equipment Leaders
In a new Deutsche Bank research report, while Buy ratings are kept on three top stock picks, price targets are slashed on all the sector leaders.
Merrill Lynch Very Positive on the Mega-Cap Bank Stocks
In a new research report, Merrill Lynch cuts earnings estimates and price targets an average 4% across the firm's 41 banks in their coverage universe.
Big Insider Buying Continues in Sprint, Lands’ End, Sears and More
While insider buying remains consistent, it does appear that the windows for executives and 10% owners to buy and sell are starting to shut ahead of earnings.
UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings
Given the massive beat-down in the sector, if these companies surpass earnings expectations, the upside could be sizable.
3 Top Tech Stocks Stand Out at Gigantic Amazon Web Services Conference
Cloud computing continues to grow almost unabated, and these Deutsche Bank stock picks give aggressive investors numerous ways to play this incredible technology trend.
Oppenheimer Upgrades 2 High-Yielding MLPs Despite Ugly Sector View
For patient long-term investors, these two MLPs may provide solid distributions during the wait for a rebound in energy pricing.
Hot Political Rhetoric Hammers Specialty Pharmaceuticals: 3 to Buy Now
We scanned the Merrill Lynch stock coverage universe for specialty pharmaceutical stocks rated Buy and found three top companies that have been crushed.